Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A spectrum of malignant tumors arising from the bone and characterized morphologically by the presence of small round cells. Ewing sarcoma and peripheral primitive neuroectodermal tumor represent the ends of a spectrum, with Ewing sarcoma lacking evidence of neural differentiation and the markers that characterize the peripheral primitive neuroectodermal tumor. Ewing sarcoma and peripheral primitive neuroectodermal tumor may share cytogenetic abnormalities, proto-oncogene expression, cell culture and immunohistochemical abnormalities. Pain and the presence of a mass are the most common clinical symptoms.
No clinical trials have been registered for Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone.
13 publications have been identified in PubMed for Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone. Research spans Case Report / Case Series (69%), Epidemiology / Natural History (15%), and Other (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 9 | 69% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 1:05 PM UTC
Common questions about Ewing sarcoma/peripheral primitive neuroectodermal tumor of bone
Disease patterns and progression |
2 |
15% |
Other research | 1 | 8% |
Laboratory research | 1 | 8% |
Gul D (2026). [PMID: 42227846](https://pubmed.ncbi.nlm.nih.gov/42227846/). *Turk Neurosurg*. [Epidemiology / Natural History]
Becker J (2025). [PMID: 40850534](https://pubmed.ncbi.nlm.nih.gov/40850534/). *Cell Signal*. [Basic Science / Preclinical]
Rabi R (2025). [PMID: 39790869](https://pubmed.ncbi.nlm.nih.gov/39790869/). *Rare Tumors*. [Case Report / Case Series]
Ravichandran P (2025). [PMID: 40153073](https://pubmed.ncbi.nlm.nih.gov/40153073/). *Childs Nerv Syst*. [Case Report / Case Series]
Gillani R (2025). [PMID: 39745975](https://pubmed.ncbi.nlm.nih.gov/39745975/). *Science*. [Epidemiology / Natural History]
Hehir-Kwa JY (2025). [PMID: 39745981](https://pubmed.ncbi.nlm.nih.gov/39745981/). *Science*. [Other]
Arcovito G (2025). [PMID: 40269875](https://pubmed.ncbi.nlm.nih.gov/40269875/). *Diagn Pathol*. [Case Report / Case Series]
Sqalli Houssaini A (2024). [PMID: 39253042](https://pubmed.ncbi.nlm.nih.gov/39253042/). *Radiol Case Rep*. [Case Report / Case Series]
Luo B (2024). [PMID: 39139288](https://pubmed.ncbi.nlm.nih.gov/39139288/). *Front Oncol*. [Case Report / Case Series]
Poojari M (2024). [PMID: 38581817](https://pubmed.ncbi.nlm.nih.gov/38581817/). *Oral Oncol*. [Case Report / Case Series]